Health Security Digest

  • Lancet

    Estimating the cost of vaccine development against epidemic infectious diseases: a cost minimisation study

    20 November 2018

    Ahead of printDimitrios Gouglas et al.,

    Vaccines can be powerful tools for preventing potential outbreaks of epidemic infectious diseases from becoming humanitarian crises. Developing these vaccines requires investment. However, evidence on what it would cost to successfully develop a sound epidemic infectious disease vaccine portfolio is scarce. This is partly because of a paucity of explicit, publicly available cost data. In addition, there is little agreement across global vaccine development funders on which epidemic infectious disease investments should be prioritised, which stems from an absence of global research and development portfolio strategy and coordination.

  • Radio NZ

    MMR vaccinations resume in Samoa

    20 November 2018

    20 NOV - Samoa's Health Ministry has resumed MMR vaccinations, after a moratorium was placed in the wake of the death of two toddlers in July.

  • Emergent biosolutions

    Emergent BioSolutions and Valneva Report Positive Phase 1 Results for Their Vaccine Candidate Against the Zika Virus

    19 November 2018

    19 NOV Via CIDRAP - The highly purified inactivated vaccine candidate, VLA1601, met the study’s primary endpoint showing a favorable safety profile in all doses and schedules tested.

    VLA1601 was also immunogenic in all treatment groups and induced both dose- and schedule-dependent neutralizing antibodies against the Zika virus with the kinetics expected for an inactivated, alum-adjuvanted whole-virus vaccine.

  • Deccan Herald

    Malaria parasite getting resistant to key drug

    19 November 2018

    19 NOV Kalyan Ray - Artemisinin resistance was reported from South Asia and Africa in the past, India was so far free from the threat that has the potential to hit malaria eradication targets set by the government. Malarial parasite Plasmodium falciparum causes the most virulent form of malaria.

  • Tempo

    Britain, Indonesia Collaborate to Improve Medical Quality

    18 November 2018

    18 NOV - Britain and Indonesia collaborated through Health Education workshops to improve the quality of medical personnel, especially for Indonesia, through cooperation and mutual exchange of inter-professional health experiences. Based on information from the British Embassy in Jakarta on Saturday, the Health Education workshop was held by several Indonesian and English institutions, namely the Department of International Trade of the British Embassy (DIT), the Young Indonesian Professional Health Community (IYHPS), and the Joint Research Ministry Committee Technology and Higher Education-Ministry of Health.

  • Lancet

    Looking beyond the Decade of Vaccines

    17 November 2018

    17 NOV - When in 2010 the global health community declared the so-called Decade of Vaccines, it marked a path towards an ambitious vision for 2020: a world in which all individuals and communities enjoy lives free from vaccine-preventable diseases.

  • Reuters

    China reports new outbreaks of African swine fever in Jiangxi, Yunnan, Sichuan and Shanghai

    17 November 2018

    17 NOV - Four new outbreaks of African swine fever have been reported in China’s provinces of Jiangxi, Yunnan and Sichuan as well as the municipality of Shanghai, the agriculture ministry said on Saturday.

  • news medical life sciences

    Group of students aim to improve malaria diagnosis using old smartphones

    16 November 2018

    16 NOV - Over 212 million cases of malaria are reported annually, with the majority of incidences occuring in Sub-Saharan Africa. However, a lack of medical resources means blood sample analysis is often delayed, leading to errors and ultimately high mortality rates. Seeking to improve the efficiency and accuracy of diagnosis, a group of students from Delft University of Technology are developing Excelscope, a semi-automated malaria diagnostic device.

  • BMC

    Evaluation of Influenza A H1N1 infection and antiviral utilization in a tertiary care hospital

    16 November 2018

    16 NOV Via Cidrap Talita Rantin Belucci et al., 

    Influenza A H1N1 infections carry a significant mortality risk. This study describes inpatients with suspected and confirmed Influenza A H1N1 infection who were prescribed oseltamivir, the risk factors associated with infection, the association between infection and mortality, and the factors associated with in-hospital mortality in infected patients.

  • Tephinet logo

    The Global Field Epidemiology Roadmap

    16 November 2018

    16 NOV - To safeguard and promote the health of its citizens, every country must have effective field epidemiology capacity. To that end, in 1980, the US Centers for Disease Control and Prevention (CDC) began supporting the development of Field Epidemiology Training Programs (FETPs) in countries throughout the world. This initiative has grown in importance since then, as many countries and regions with inadequate public health capacities face public health threats of increasing scope and complexity.

Pages

Subscribe to  Health Security Digest